Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Financial Flexibility Index
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-9.54 Million (operating CF CN¥-17.57 Million minus capex CN¥8.02 Million) represents 0% of total liabilities (CN¥567.12 Million). Also explore Gansu Longshenrongfa Pharmaceutical Indu (300534) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. Check 300534 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For the full company profile including market capitalisation, see how much is Gansu Longshenrongfa Pharmaceutical Indu worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥36.83 Million | CN¥-6.54 Million | CN¥613.42 Million | ▼ -83.7% |
| 2024 | 0.37x | CN¥248.36 Million | CN¥170.14 Million | CN¥674.39 Million | ▲ +3.3% |
| 2023 | 0.36x | CN¥222.89 Million | CN¥96.53 Million | CN¥625.14 Million | ▲ +113.0% |
| 2022 | 0.17x | CN¥25.05 Million | CN¥11.43 Million | CN¥149.66 Million | ▼ -70.4% |
| 2021 | 0.56x | CN¥51.55 Million | CN¥51.13 Million | CN¥91.24 Million | ▲ +16.1% |
| 2020 | 0.49x | CN¥62.05 Million | CN¥43.50 Million | CN¥127.53 Million | ▼ -38.9% |
| 2019 | 0.80x | CN¥56.73 Million | CN¥28.21 Million | CN¥71.26 Million | ▲ +253.0% |
| 2018 | 0.23x | CN¥13.01 Million | CN¥10.23 Million | CN¥57.68 Million | ▼ -70.6% |
| 2017 | 0.77x | CN¥53.67 Million | CN¥-2.05 Million | CN¥70.04 Million | ▼ -30.8% |
| 2016 | 1.11x | CN¥66.17 Million | CN¥13.14 Million | CN¥59.74 Million | ▲ +36.8% |
| 2015 | 0.81x | CN¥195.26 Million | CN¥30.60 Million | CN¥241.17 Million | ▼ -32.5% |
| 2014 | 1.20x | CN¥138.36 Million | CN¥39.01 Million | CN¥115.40 Million | ▲ +67.2% |
| 2013 | 0.72x | CN¥96.86 Million | CN¥35.92 Million | CN¥135.04 Million | ▲ +47.7% |
| 2012 | 0.49x | CN¥59.78 Million | CN¥35.62 Million | CN¥123.07 Million | ▲ +63.2% |
| 2011 | 0.30x | CN¥22.37 Million | CN¥10.16 Million | CN¥75.15 Million | — |